Irinotecan + ELRAGLUSIB

4 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Irinotecan + ELRAGLUSIB
Treatment and conditionWhere it standsTrials
Irinotecan + ELRAGLUSIB for gliomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + ELRAGLUSIB for hereditary sensory and autonomic neuropathiesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + ELRAGLUSIB for neoplasm metastasisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Irinotecan + ELRAGLUSIB for sarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1